Therapeutical Class：Lincosamide antibiotics, inhibits bacterial protein synthesis by binding with 50S ribosomal subunits

Indication：Treatment of susceptible bacterial infections, mainly those caused by anaerobes, streptococci, pneumococci, and staphylococci.

Administraton：

Adults:

PO 150-450 mg q6-8h, max. 1.8g/day; taken with a full glass of water to avoid esophageal irritation.

IM or IV 1.2-2.7 g/day in 2-4 divided doses, to a max of 4.8 g/day.

Children: PO 8-20 mg/kg/day in 3-4 divided doses.

IM or IV:

<1 month: 15-20 mg/kg/day in 3-4 divided doses.

1 month: 20-40 mg/kg/day in 3-4 divided doses.

Dose adjustment in hepatic impairment.

Adverse Effect：Anorexia, nausea, vomiting, cramps, diarrhea, pseudomembranous colitis, rash.

Pregnancy Risk：B

Supply：Clincin XE “Clincin” Inj 300mg/2cc（克力欣注射液 南光）＜02465＞

Clindamycin XE “Clindamycin” Cap 150mg（克林達黴素膠囊 景德）＜10895＞